|
1
|
Bertens CJF, van Mechelen RJS, Berendschot TTJM, Gijs M, Wolters JEJ, Gorgels TGMF, Nuijts RMMA, Beckers HJM. Repeatability, reproducibility, and agreement of three tonometers for measuring intraocular pressure in rabbits. Sci Rep 2021; 11:19217. [PMID: 34584185 PMCID: PMC8478901 DOI: 10.1038/s41598-021-98762-7] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2021] [Accepted: 09/14/2021] [Indexed: 12/04/2022] Open
Abstract
The aim of this study was to evaluate repeatability, reproducibility, and agreement of three commonly used tonometers in animal research (TonoLab, TonoVet, and TonoPEN AVIA) in a cohort of 24 rabbits. Additionally, the impact of sedation on IOP was investigated in 21 New Zealand White rabbits with the TonoVet tonometer. Repeatability was determined using the coefficient of variation (CoV) for two observers. For the TonoLab (6.55%) and TonoVet (6.38%) the CoV was lower than for the TonoPEN AVIA (10.88%). The reproducibility was highest for the TonoVet (0.2 ± 3.3 mmHg), followed by the TonoLab (0 ± 12.89 mmHg) and lowest for the TonoPEN AVIA (− 1.48 ± 10.3 mmHg). The TonoLab and TonoVet showed the highest agreement (r = 0.85, R2 = 0.73). After sedation, a significant IOP reduction (often > 25%) was observed. Our results show that among the three tonometers tested, the TonoVet tonometer is best for use in rabbits while the TonoLab should be avoided. The impact of sedation on IOP was substantial and should be taken into account during experimentation.
Collapse
Affiliation(s)
- Christian J F Bertens
- Department of Ophthalmology, University Eye Clinic Maastricht, School for Mental Health and Neuroscience (MHeNs), Maastricht University Medical Center+ (MUMC+), P. Debyelaan 25, PO Box 5800, 6229 HX, Maastricht, The Netherlands. .,Chemelot Institute for Science and Technology (InSciTe), Gaetano Martinolaan 63-65, 6229 GS, Maastricht, The Netherlands.
| | - Ralph J S van Mechelen
- Department of Ophthalmology, University Eye Clinic Maastricht, School for Mental Health and Neuroscience (MHeNs), Maastricht University Medical Center+ (MUMC+), P. Debyelaan 25, PO Box 5800, 6229 HX, Maastricht, The Netherlands.,Chemelot Institute for Science and Technology (InSciTe), Gaetano Martinolaan 63-65, 6229 GS, Maastricht, The Netherlands
| | - Tos T J M Berendschot
- Department of Ophthalmology, University Eye Clinic Maastricht, School for Mental Health and Neuroscience (MHeNs), Maastricht University Medical Center+ (MUMC+), P. Debyelaan 25, PO Box 5800, 6229 HX, Maastricht, The Netherlands
| | - Marlies Gijs
- Department of Ophthalmology, University Eye Clinic Maastricht, School for Mental Health and Neuroscience (MHeNs), Maastricht University Medical Center+ (MUMC+), P. Debyelaan 25, PO Box 5800, 6229 HX, Maastricht, The Netherlands.,Chemelot Institute for Science and Technology (InSciTe), Gaetano Martinolaan 63-65, 6229 GS, Maastricht, The Netherlands
| | - Jarno E J Wolters
- Department of Ophthalmology, University Eye Clinic Maastricht, School for Mental Health and Neuroscience (MHeNs), Maastricht University Medical Center+ (MUMC+), P. Debyelaan 25, PO Box 5800, 6229 HX, Maastricht, The Netherlands.,Chemelot Institute for Science and Technology (InSciTe), Gaetano Martinolaan 63-65, 6229 GS, Maastricht, The Netherlands
| | - Theo G M F Gorgels
- Department of Ophthalmology, University Eye Clinic Maastricht, School for Mental Health and Neuroscience (MHeNs), Maastricht University Medical Center+ (MUMC+), P. Debyelaan 25, PO Box 5800, 6229 HX, Maastricht, The Netherlands.,Chemelot Institute for Science and Technology (InSciTe), Gaetano Martinolaan 63-65, 6229 GS, Maastricht, The Netherlands
| | - Rudy M M A Nuijts
- Department of Ophthalmology, University Eye Clinic Maastricht, School for Mental Health and Neuroscience (MHeNs), Maastricht University Medical Center+ (MUMC+), P. Debyelaan 25, PO Box 5800, 6229 HX, Maastricht, The Netherlands.,Chemelot Institute for Science and Technology (InSciTe), Gaetano Martinolaan 63-65, 6229 GS, Maastricht, The Netherlands
| | - Henny J M Beckers
- Department of Ophthalmology, University Eye Clinic Maastricht, School for Mental Health and Neuroscience (MHeNs), Maastricht University Medical Center+ (MUMC+), P. Debyelaan 25, PO Box 5800, 6229 HX, Maastricht, The Netherlands.,Chemelot Institute for Science and Technology (InSciTe), Gaetano Martinolaan 63-65, 6229 GS, Maastricht, The Netherlands
| |
Collapse
|
|
2
|
Szabo E, Patko E, Vaczy A, Molitor D, Csutak A, Toth G, Reglodi D, Atlasz T. Retinoprotective Effects of PACAP Eye Drops in Microbead-Induced Glaucoma Model in Rats. Int J Mol Sci 2021; 22:8825. [PMID: 34445531 PMCID: PMC8396165 DOI: 10.3390/ijms22168825] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2021] [Revised: 08/09/2021] [Accepted: 08/13/2021] [Indexed: 01/29/2023] Open
Abstract
Glaucoma is associated with increased intraocular pressure (IOP), causing the apoptosis of retinal ganglion cells (RGCs) and the loss of their axons leading to blindness. Pituitary adenylate cyclase activating polypeptide (PACAP) is neuroprotective in several neural injuries, including retinopathies. The aim of this study was to investigate the effects of PACAP1-38 eye drops in a model of glaucoma. IOP was elevated bilaterally by injections of microbeads to block the aqueous humor outflow. The control groups received the same volume of saline. Animals were treated with PACAP1-38 (1 µg/drop, 3 × 1 drop/day) or vehicle for 4 weeks starting one day after the injections. Retinal morphology by histology and optical coherence tomography, function by electroretinography, and IOP changes were analyzed. Animals were sacrificed 8 weeks after the injections. Microbeads injections induced a significant increase in the IOP, while PACAP1-38 treatment lowered it to normal levels (~10 mmHg). Significant retinal degeneration and functional impairment were observed in the microbead-injected group without PACAP1-38 treatment. In the microbeads + PACAP1-38 group, the retinal morphology and functionality were close to the normal values. In summary, our results show that PACAP1-38, given in form of eye drops, is neuroprotective in glaucoma, providing the basis for potential future therapeutic administration.
Collapse
Affiliation(s)
- Edina Szabo
- Department of Anatomy, MTA-PTE PACAP Research Team, University of Pecs Medical School, 7624 Pecs, Hungary; (E.S.); (E.P.); (A.V.); (D.M.); (D.R.)
| | - Evelin Patko
- Department of Anatomy, MTA-PTE PACAP Research Team, University of Pecs Medical School, 7624 Pecs, Hungary; (E.S.); (E.P.); (A.V.); (D.M.); (D.R.)
| | - Alexandra Vaczy
- Department of Anatomy, MTA-PTE PACAP Research Team, University of Pecs Medical School, 7624 Pecs, Hungary; (E.S.); (E.P.); (A.V.); (D.M.); (D.R.)
| | - Dorottya Molitor
- Department of Anatomy, MTA-PTE PACAP Research Team, University of Pecs Medical School, 7624 Pecs, Hungary; (E.S.); (E.P.); (A.V.); (D.M.); (D.R.)
| | - Adrienne Csutak
- Department of Ophthalmology, Clinical Centre, University of Pecs Medical School, 7632 Pecs, Hungary;
| | - Gabor Toth
- Department of Medical Chemistry, Faculty of Medicine, University of Szeged, 6720 Szeged, Hungary;
| | - Dora Reglodi
- Department of Anatomy, MTA-PTE PACAP Research Team, University of Pecs Medical School, 7624 Pecs, Hungary; (E.S.); (E.P.); (A.V.); (D.M.); (D.R.)
- Szentagothai Research Center, University of Pecs, 7624 Pecs, Hungary
| | - Tamas Atlasz
- Department of Anatomy, MTA-PTE PACAP Research Team, University of Pecs Medical School, 7624 Pecs, Hungary; (E.S.); (E.P.); (A.V.); (D.M.); (D.R.)
- Szentagothai Research Center, University of Pecs, 7624 Pecs, Hungary
- Department of Sportbiology, University of Pecs, 7624 Pecs, Hungary
| |
Collapse
|